FENNEC PHARMACEUTICALS INC. Form 4 Filing

This filing details a transaction by Pierre Sayad, Chief Medical Officer of FENNEC PHARMACEUTICALS INC., on April 30, 2026. Sayad acquired 168 Common Shares through a release from restriction, with the shares originally awarded on March 28, 2025. The acquisition price was $0.00 per share. Following this transaction, Sayad holds a total of 20,847 Common Shares, all of which are held directly.